Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Yael L. Maxwell

August 29, 2016

News Daily News

Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9

Yael L. Maxwell

August 29, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Daily News

Does New Dual-Modality Imaging Come Closer to Uncovering Vulnerable Plaques?

Todd Neale

March 14, 2016

News Daily News

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

Michael O'Riordan

March 07, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Daily News

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

March 13, 2014

News Daily News

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Yael L. Maxwell

August 30, 2013

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Daily News

Virtual Histology IVUS Links Vulnerable Plaque to Future Events

August 17, 2011

Advertisement

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

What’s Going to Be Hot at TCT 2025

Top Coronary Artery Disease News of 2022

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds

Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Does New Dual-Modality Imaging Come Closer to Uncovering Vulnerable Plaques?

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Virtual Histology IVUS Links Vulnerable Plaque to Future Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content